Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2010
11/11/2010WO2010129665A2 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128346A2 Rosuvastatin salts and method for preparation thereof
11/11/2010WO2010128102A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2010127928A1 Insecticidal compounds
11/11/2010WO2010127608A1 Heterocyclic substituted acardite derivates and use thereof
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010WO2010091877A3 Process for producing ambrisentan
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
11/11/2010US20100286171 Phenylacetamide derivative
11/11/2010US20100286169 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds
11/11/2010US20100286032 Prodrugs of hiv protease inhibitors
11/11/2010US20100285963 Substituted fluoroalkoxyphenylsulfonylureas
11/11/2010CA2760464A1 Carboxamide compounds and their use as calpain inhibitors
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2759592A1 Insecticidal compounds
11/10/2010EP2248806A2 Quinazoline derivatives as tyrosine kinase inhibitors
11/10/2010EP2248805A2 Method of synthesis of bosentan, its polymorphic forms and its salts
11/10/2010EP2247739A2 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl) methyl carboxylate and process for its production employing a 2-deoxyribose-5-phosphate aldolase
11/10/2010EP2247579A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
11/10/2010EP2247578A1 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/10/2010EP1940407B1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
11/10/2010CN1918134B Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors
11/10/2010CN101883759A 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides
11/10/2010CN101880273A Benzo-hexahydric N-heterocyclic derivatives, preparation method and application thereof in medicines
11/10/2010CN101880211A Method for preparing sulfonyl ring thiourea from mono-sulfonyl diamine in aqueous phase
11/10/2010CN101486684B Preparation of 2,4-dichloro-5-methoxy pyrimidine
11/10/2010CN101318935B Method for preparing hydrochloric 1-(2-pyrimidine) diethylenediamine compound
11/09/2010US7829708 such as psoriasis and inflammatory bowel disease, in a human or other host animals; 2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid
11/09/2010US7829706 Pyrimidinium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
11/09/2010US7829703 2-Fluoro-6-[(4,6-dimethoxytriazin-2-yl)carbonyl]-N-difluoromethanesulfonanilide; controlling paddy crop weeds; reacting 2-Chloro-6-[(4,6-dimethoxytriazin-2-yl)methyl]aniline with difluoromethanesulfonyl chloride; controlling weeds which express resistance against existing herbicides
11/09/2010US7829566 4-amino-quinazolines
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
11/09/2010US7829560 such as N-(4-{[2-(4-Ethylpiperazin-1-yl)pyrimidin-4-yl]oxy}-1-naphthyl)-3-fluoro-5-piperidin-1-ylbenzamide, useful as antiproliferative agents or in treating arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, autoimmune or inflammatory diseases
11/09/2010CA2498122C Process for the preparation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy) quinazoline
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010125991A1 Method for control of fish parasites
11/04/2010WO2010125332A1 Method of controlling undesired vegetation
11/04/2010WO2010103362A3 Process for the preparation of bosentan
11/04/2010WO2010077062A3 Preparation method of statin compound and benzothiazolyl sulfone compound used therein
11/04/2010WO2010075558A3 Compositions and methods for inhibition of the jak pathway
11/04/2010WO2010068863A3 Pyrimidine compounds and methods of making and using same
11/04/2010WO2009128091A3 Crystalline form of(7-[4-(4-fluorophenyl)-6-isopropyl-2-(n- methyl-n-methylsulfonylamino)pyrimidin-5-yl]-(3r,5s)- dihydroxy-(e)-6-heptenoic acid intermediate, process for preparing the same and use thereof
11/04/2010WO2009117080A8 Quinazoline derivatives as raf kinase modulators and methods of use thereof
11/04/2010US20100280244 Process for preparing n-substituted hydroxypyrimidinone carboxamides
11/04/2010US20100280242 Method of Preparing Cyclic Carbonates, Cyclic Carbamates, Cyclic Ureas, Cyclic Thiocarbonates, Cyclic Thiocarbamates, and Cyclic Dithiocarbonates
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280054 Multicyclic amino acid derivatives and methods of their use
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100277063 Fluorene-based derivative and organic electroluminescence device employing the same
11/04/2010CA2759155A1 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
11/03/2010EP2246335A1 Aminopyridineamides as pesticides
11/03/2010EP2245018A1 Process for preparing bosentan
11/03/2010EP2245017A2 Novel heterocycles
11/03/2010EP2244574A1 Tricyclic compounds as modulators of tnf- synthesis and as pde4 inhibitors
11/03/2010EP1805155B1 Thrombopoietin activity modulating compounds and methods
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN101878203A Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
11/03/2010CN101878031A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/03/2010CN101875639A Substituted pyrimidinyl ether compound and application thereof
11/03/2010CN101875635A Annular guanidinium ionic liquid and preparation method therof
11/03/2010CN101875631A Dye composition
11/03/2010CN101456845B 4,5-diaryl-2-sulfhydryl miazines compounds and synthetic method thereof and pharmaceutical use
11/03/2010CN101265234B Method for synthesizing aditoprim
11/02/2010US7825246 Bi-aryl meta-pyrimidine inhibitors of kinases
11/02/2010US7825245 Antitumor agents
11/02/2010US7825244 4-(7-chloro-quinazolin-4-yl)-piperidine; use in the synthesis of protein tyrosine kinase inhibitors, particularly inhibitors of FLT3 and/or c-kit and/or TrkB
11/02/2010US7825128 such as N-(ethoxycarbonyl)-S-(4-{[4-{[(R)-2-hydroxy-1-methylethyl]amino}-5-(2-thienyl)pyrimidine-2-yl]amino}phenyl)-S-methylsulfoximide, used for the treatment of breast cancer and rheumatoid arthritis
11/02/2010US7825121 useful as selective CCR5 antagonists; use of a combination of a CCR5 antagonist of this invention and one or more antiviral or other agents in the treatment of HIV
11/02/2010US7825116 N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines
11/02/2010CA2497544C Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2400167C Insecticidal anthranilamides
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123975A1 Novel anti-inflammatory agents
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122082A1 Heterocyclic antiviral compounds
10/28/2010WO2010093849A3 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/28/2010WO2009114814A3 Therapeutic substances that modulate genome methylation
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100274015 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
10/28/2010US20100274014 Process for manufacturing rosuvastatin potassium and crystalline and amorphous forms thereof
10/28/2010US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds
10/28/2010US20100273816 Quinazoline Compounds
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759655A1 Heteroaryl compounds and uses thereof
10/28/2010CA2759264A1 Diacylethylenediamine compound
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 427